Dear Dr. {{$doctorName}},
Subject: In-Practice Usage and Performance (IPUP)Study of Prohance™ Junior;
Study code: IPUP/Prohance™ Junior /Ped/Pharma care/April2023.
Good nutrition is essential for survival, physical growth, mental development,
performance, productivity, health and well-being across the entire life-span: from the
earliest stages of fetal development, at birth, and through infancy, childhood, adolescence
and on into adulthood. Children need proper nutrients to grow, stay healthy and strong.
Research studies show that nutrition in a child’s early years is linked to their health and
academic performance in later years.
The Dietary Guidelines state that nutritional needs should be met primarily through diet. If
the child is generally healthy and eats a wide variety of foods, including fruits,
vegetables, whole grains, legumes, low-fat dairy products, they probably don't need
supplements. But for some children, supplements may be a useful way to get nutrients
they might otherwise lack..
Prohance™ Junior is a scientifically formulated all-round nutritional formula which
contains micro and macro nutrients known to support height gain, aid brain development,
eye health and help in immune health. It contains 37 vital nutrients including 13 vitamins
& 14 minerals. Prohance™ Junior are marketed by the ‘Pharma care’ team of Sun
Pharmaceutical Industries Ltd.
Although every product is marketed only after regulatory approval, it is important to know how it performs in day-to-day practice of individual medical practitioners. For this purpose, we have planed to conduct a cross sectional study to assess the real-life performance of ‘Prohance™ Junior ’ in pediatric patient pediatric patients who are undernourished or at risk of undernutrion.
We invite you to participate in this study. All you need to do is to report on a standard form your experience with ‘Prohance™ Junior ’ in these patient’s (to avoid any bias) in whom you prescribe this product in the normal course of your practice. Thus, this is not an experimental study because the product will be prescribed and purchased as you and your patient’s normally do.
If you agree to participate, you will need to copy the relevant information from the
suggested number of patient’s case papers, and investigational reports, if any (which we
call source documents), on to the standard case report forms (which we call CRF).
CRF has to be verified to ensure that the CRF signed by you are free from errors or omissions. Let us assure you that the CRF will not contain the patients’ names, so as to ensure confidentiality.
If any serious adverse events (AE) occur during ‘Prohance™ Junior ’ therapy, you will be
expected to report them to the monitor or to me immediately on the AE reporting form.
As you will be spending some extra time to keep, copy and verify these patient’s records,
we offer to pay you by cheque a professional fee of Rs. {{$contractAmount}}/- .
We trust you and we are partners in promoting safe and effective drug therapy. In that spirit,
we hope you will consent to participate in this study. If you do, please sign and return the
enclosed reply along with your visiting card for accuracy of records.
|
}}){kind=logo}
}})